Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan effects on insulin sensitivity and IGF-I bioactivity in prediabetes
NL-OMON35702Active, not recruiting
- Sponsor
- Ikazia Ziekenhuis
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of losartan in prediabetes and impaired fasting glucose (IFG), sponsored by Ikazia Ziekenhuis. Primary endpoint: Baseline-adjusted difference in HOMA at 8 weeks. Started Aug 2012; status: active, not recruiting.
02
Drugs
losartan
03
Conditions
prediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on NL-OMON35702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35702.